Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NCEL
NCEL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NCEL News
NewcelX Appoints Diabetes Research Authority Dr. Camillo Ricordi to Advisory Board
5h ago
Newsfilter
Avaí Bio Completes GMP Master Cell Bank for Anti-Aging Therapy
5h ago
Newsfilter
NewcelX Completes Successful FDA Meeting, Advancing Diabetes Treatment
Jul 01 2026
Newsfilter
NewcelX Publishes AstroRx® Study Results
Jun 15 2026
Newsfilter
Tango Therapeutics Shares Surge Over 50% on Positive Trial Data
Jun 09 2026
NASDAQ.COM
NewcelX Schedules Pre-IND Meeting with FDA to Advance Type 1 Diabetes Treatment
May 27 2026
Newsfilter
NLS Pharmaceutics Reports FY 2025 Financial Results
May 01 2026
seekingalpha
NewcelX Collaborates with Eledon to Advance Diabetes Treatment
Apr 20 2026
Newsfilter
NewcelX Announces Private Placement at 30% Premium, Stock Rises
Apr 01 2026
seekingalpha
NewcelX Secures Strong Financing to Advance Type 1 Diabetes Program
Apr 01 2026
Newsfilter
NewcelX Collaborates with Eledon to Advance Diabetes Treatment
Mar 09 2026
PRnewswire
NewcelX Collaborates with Eledon to Advance Diabetes Treatment
Mar 09 2026
Newsfilter
NewcelX Publishes Key Scientific Review Enhancing Strategic Positioning
Feb 12 2026
PRnewswire
NewcelX Focuses on Type 1 Diabetes Cell Therapy
Jan 29 2026
PRnewswire
NewcelX Appoints Diabetes Expert Dr. Julien Boisdron to Scientific Advisory Board
Jan 05 2026
PRnewswire
NewcelX Appoints Diabetes Expert Dr. Julien Boisdron to Scientific Advisory Board
Jan 05 2026
Newsfilter
Show More News
